![logo](/logos/ELTP.webp)
Elite Pharmaceuticals, Inc.
OTC:ELTP
0.15 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Elite Pharmaceuticals, Inc. |
Symbool | ELTP |
Munteenheid | USD |
Prijs | 0.152 |
Beurswaarde | 154,115,840 |
Dividendpercentage | 0% |
52-weken bereik | 0.03 - 0.17 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nasrat Hakim |
Website | https://www.elitepharma.com |
An error occurred while fetching data.
Over Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)